Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Gong G, Shong YK: Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrino (Oxf).2009;71(4):581-6
Kim EY, Kim WG, Kim WB, Kim TY, Ryu JS, Gong G, Yoon JH,Honh SJ,Lee JH,Shong YK: Clinical Outcomes of Persistent Radioiodine Uptake in Neck shown by Diagnostic Whole Body Scan in Patients with Differentiated Thyroid Carcinoma after Initial Surgery and Remnant Ablation. Clin Endocinol (Oxf).2010 Aug73(2):257-63.
Kim EY , Kim TY, Kim WG, Yim JH, Han JM. Ryu JS, Hong SJ, Yoon YH, Gong GY, Kim WB, Shong YK : Effects ofdifferent doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in paients with differentiated thyroid carcinoma. Nucl Med Commun. 2011; 32(10): 954-9.
Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Gong G, Hong SJ, Shong YK : The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab. 2011;96(7):2049-56
Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Moon DH,Sung TY, Yoon JH,Kim SC, Hong SJ, Shong YK: Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation. J Clin Endocrinol Metab. 2011;96(12):3695-700
Kim WG, Choi HJ, Kim WB, Kim EY, Yim JH, Kim TY, Gong G, Kim SY, Chung N, Shong YK: Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas. J Endocrinol Invest. 2011 Sep 6 Epub
Kim WG, Rye JS ,Kim EY,Lee JH, Baek JH,Yoon JH, Hong SH,Kim ES,Kim TY, Kim WB, Shong YK: Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin but negative cervical sonography and 18 F-fluordodeoxyglucose positron emission tomography scan. J Clin Endocrinol Metab.2010;95(3):1169-73
Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Rye JS, Gong G, Hong SH, Shong YK: Change of Serum Anti-ThyroglobulinAntibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin Negative Patients with Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab.2008;93(12):4683-9
Kim WG, Kim EY, Kim TY, Ryu JS, Hong SJ, Kim WB, Shong YK : Redifferentiation Therapy with 13-cis Retinoic Acids in Radioiodine-Resistant Thyroid Cancer. Endocr J. 2009;56(1):105-12
Kim WG, Gong G, Kim EY, Kim TY, Hong SJ, Kim WB, Shong YK: Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma inthe same thyroid should be considered as coincidental. Clin Endocrinol 2010;72(2) ;256-263
최현정, 김태용, 김의영, 김원구, 김원배, 송영기: 심바스타틴이 미분화 갑상선암 세포주의 성장과 침습에 미치는 영향. 대한내분비학회지 2008;23(4):238-244
Oh TH, Kim MH, Lee SK, Seo DW, Lee SS, Kim EY, Song JH, Jung JH, Lee SA, Lee SG, Park SH, Jang SJ: Thirteen cases of intrahepatic billiary cystadenoma and cystadenocarcinoma : a single center experience. Korean J Gastroenerol. 2006 May;47(5):379-385
김원구,최현정,김의영,김태용,김성철,송영기: Peroxisome Proliferator-Activated Receptor(PPAR) Delta 가갑상선암 세포주의 성장 및 침습에 미치는 영향. 대한내분비학회지. 2009;24(1):25-322009
한두희,최현정,김원구,김의영,김태용,김원배 등: sunitinib 이 갑상선 유두암 세포주의 성장 및 침습에 미치는 영향. 대한 갑상선학회지 2009;2(02) 105-113
Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients. 2010;34(2):95-100
<연구발표>
Kim EY,Kim TY, Kim WG, Kim ES, Shong YK, Kim WB: DNA binding activites of STAT3 are decreased in human papillary thyroid cancer tissues. 90th Annual Meeting of Endocrine Society (2008 Jun 15)
Kim EY,Kim WG,Kim WB,Kim TY, Ryu JS, Gong G. Yoon JH, Hong SJ,Shong YK: A comparison of Success Rate and Prognosis According to I-131 Administred Dose for Postoperative Thyroid Remnant Ablation in Differentiated Thyroid Carcinoma. The 9th Asia and Oceania Thyroid Association Congress
Kim EY, Kim WG, Kim WB, Kim TY, Ryu JS, Gong G. Yoon JH, Hong SJ,Shong YK : Clinical outcome of persistent radioiodine uptake on thyroid bed at diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation; comparision of between patients with second ablation and untreated patients. The 9th Asia and Oceania Thyroid Association Congress